Peter Martin

Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphoma

Yucai Wang, Melissa C. Larson, Steven R. Hwang, Diego Villa et autres

ABSTRACT: The benefit of rituximab maintenance after first-line (1L) bendamustine-rituximab (BR) in patients with mantle cell lymphoma (MCL) remains uncertain, with inconsistent results from the phase 2 MAINTAIN trial and several retrospective studies. We conducted a large retrospective study at 27 US …

us, ca (code pays fourni par la source)

Shorter diagnosis to treatment interval is associated with poor prognosis in patients with peripheral T-cell lymphoma: Analysis from the LEO and MER cohorts

Neha Mehta-Shah, Melissa C. Larson, Eric Mou, Pamela Allen et autres

Abstract Background Previous studies in aggressive B-cell lymphoma demonstrate that patients with shorter diagnosis-to-treatment intervals (DTI) represent those with higher risk disease. This suggests that patients enrolled in clinical trials may carry a selection bias as they often have longer DTI than …

us, ch, mx (code pays fourni par la source)

Young Persons’ Experiences of Inpatient Care for Self-Harm: A Qualitative Exploration

Francois Potgieter, Peter Martin

gb (code pays fourni par la source)

Leveraging BRG1 Driven Ferroptosis Resistance to Overcome Treatment Resistance

Soo‐Yeon Hwang, Helgi Nikolli, Belem Yoval‐Sánchez, Peter Martin et autres

Resistance to Bruton's tyrosine kinase inhibitors (BTKi) remains a major therapeutic challenge in B-cell malignancies, limiting treatment durability. Here, we identify ferroptosis suppression as a central mechanism of BTKi resistance in mantle cell lymphoma (MCL). Aberrant BRG1 activity protects cells from BTKi-induced …

us, kr (code pays fourni par la source)

Subsets of follicular lymphoma 3B have divergent outcomes: results from the prospective multicenter MER and LEO cohorts

Patrizia Mondello, Brianna J. Negaard, Andrew L. Feldman, Brian K. Link et autres

Follicular lymphoma (FL) 3B is considered an aggressive lymphoma, however recent studies have challenged this paradigm. Additional controversy involves the clinical implication of pure FL3B (FL3Bp) vs FL3B with concurrent diffuse large B cell lymphoma (DLBCL) (FL3Bc). To address these questions, we …

us (code pays fourni par la source)

What patients with cancer require from their clinicians to enable uptake of exercise as part of cancer care: A mixed methods study

Prue Cormie, Ashleigh Bradford, Lisa Guccione, Peter Martin et autres

PURPOSE: Despite robust evidence and a series of evidence-based guidelines stating the benefits of exercise for cancer patients, uptake remains low. This study aimed to explore and describe what patients with cancer require from their clinicians to enable uptake of exercise as …

au, dk, es (code pays fourni par la source)

Cross-Cultural Adaptation and Patient Evaluations of a Question Prompt List for Danish-Speaking Patients at the Orthopaedic Surgery Department, Odense University Hospital

Nina Høy Chodkiewicz, Meg Chiswell, Peter Martin, Christina Louise Lindhardt

OBJECTIVES: The Question Prompt List (QPL) enhances patients' consultation preparation by improving health literacy and communication with healthcare professionals. A validated tool for this context is not yet available. We adapted and translated an Australian QPL to ensure its validity. This study …

dk, au (code pays fourni par la source)

Improvements in Outcomes in Older Patients With Mantle Cell Lymphoma Are Associated With Improvements Across Multiple Lines of Therapy

Danny Luan, Neela Easwar, Zhengming Chen, Brian K. Link et autres

us (code pays fourni par la source)

Willingness to pay for exercise oncology services: a mixed methods study

Prue Cormie, Ashleigh Bradford, Christopher M. Doran, Boyd Potts et autres

au (code pays fourni par la source)

Research Practices in Classifying Dimensional Models of Adversity: A Scoping Review

Sidonie Kilpatrick Roque, Peter Martin, Yvonne Kelly, Rebecca Lacey

gb (code pays fourni par la source)

Frontline R-CHOP and BR Have Similar Outcomes By SUVmax in Follicular Lymphoma

Patrizia Mondello, Brianna J Negaard, Luca Arcaini, Joshua W.D. Tobin et autres

Background: Positron emission tomography (PET) scan is the imaging modality of choice for initial staging and response assessment of follicular lymphoma (FL). Quantitative parameters such as standardized uptake value (SUV) have been investigated as putative prognosticators in FL, with high baseline SUVmax …

us, it, au, fr (code pays fourni par la source)

Subsets of Follicular Lymphoma (FL) 3B Have Divergent Biological Behavior and Clinical Outcome: Results from the Prospective Multicenter MER and LEO Cohorts

Patrizia Mondello, Brianna J Negaard, Andrew L. Feldman, Brian K. Link et autres

Background: FL3B is the least common among FL subtypes, accounting for 5-10% of cases. Almost half of FL3B tumors have concurrent diffuse large B cell lymphoma (DLBCL) in the diagnostic tissue biopsy, while FL3B rarely coexists with FL1-2 or FL3A. Several lines …

us (code pays fourni par la source)